Get the Stockscreener App
4.99
1.38%
-0.07
After Hours:
5.00
0.010
+0.20%
Abeona Therapeutics Inc stock is traded at $4.99, with a volume of 836.84K.
It is down -1.38% in the last 24 hours and down -2.16% over the past month.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
See More
Previous Close:
$5.06
Open:
$5.09
24h Volume:
836.84K
Relative Volume:
0.53
Market Cap:
$270.41M
Revenue:
-
Net Income/Loss:
$-54.19M
P/E Ratio:
-1.9341
EPS:
-2.58
Net Cash Flow:
$-37.34M
1W Performance:
+1.84%
1M Performance:
-2.16%
6M Performance:
-21.79%
1Y Performance:
-16.83%
1-Day Range:
$4.935
$5.13
1-Week Range:
$4.9301
$5.26
52-Week Range:
$3.9328
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Name
Abeona Therapeutics Inc
Sector
Industry
Phone
646-813-4701
Address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Compare ABEO vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
4.99 | 274.21M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Mar-05-25 | Initiated | Oppenheimer | Outperform |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| May-30-24 | Initiated | Stifel | Buy |
| Nov-11-20 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-18-20 | Initiated | B. Riley FBR | Buy |
| Feb-10-20 | Initiated | SVB Leerink | Outperform |
| Dec-10-19 | Resumed | Cantor Fitzgerald | Neutral |
| Aug-15-19 | Downgrade | Maxim Group | Buy → Hold |
| Aug-12-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-26-19 | Downgrade | Mizuho | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Oct-12-18 | Initiated | Mizuho | Buy |
| Jun-05-18 | Initiated | Seaport Global Securities | Buy |
| Nov-08-17 | Initiated | SunTrust | Buy |
| Oct-16-17 | Reiterated | H.C. Wainwright | Buy |
| Oct-11-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Oct-10-17 | Initiated | Citigroup | Buy |
| Oct-05-17 | Reiterated | Maxim Group | Buy |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Jul-18-17 | Reiterated | Maxim Group | Buy |
| Jun-22-17 | Resumed | Jefferies | Buy |
| Jan-06-17 | Initiated | Jefferies | Buy |
| Sep-29-16 | Reiterated | Maxim Group | Buy |
View All
Abeona Therapeutics Inc Stock (ABEO) Latest News
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Seven new Abeona hires get 3-year stock grants as inducement - Stock Titan
Behavioral Patterns of ABEO and Institutional Flows - Stock Traders Daily
Abeona Therapeutics (NASDAQ:ABEO) Director Sells 20,070 Shares - MarketBeat
Abeona sells Rare Pediatric Disease PRV for $155M - MSN
Crombez Eric sells Abeona Therapeutics (ABEO) shares for $82895 By Investing.com - Investing.com Nigeria
Abeona Therapeutics director sells $75k in stock By Investing.com - Investing.com South Africa
Crombez Eric sells Abeona Therapeutics (ABEO) shares for $82895 - Investing.com
Abeona Therapeutics director sells $75k in stock - Investing.com
Abeona Therapeutics (NASDAQ:ABEO) Director Eric Crombez Sells 16,284 Shares - MarketBeat
Abeona Therapeutics (NASDAQ:ABEO) Director Mark Alvino Sells 2,000 Shares - MarketBeat
Leila Alland Sells 18,065 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock - MarketBeat
Insider-Favored Growth Companies To Watch February 2026 - simplywall.st
Merger Talk: Is Abeona Therapeutics Inc in a bullish channelSwing Trade & Stock Timing and Entry Methods - baoquankhu1.vn
Sentiment Watch: How does FVNNU score in quality rankingsBond Market & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Dividend Watch: How does CBTJ correlate with NasdaqWeekly Gains Summary & Accurate Buy Signal Notifications - baoquankhu1.vn
Is Abeona Therapeutics Inc. stock forming a cup and handleJuly 2025 Highlights & Reliable Volume Spike Alerts - mfd.ru
(ABEO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
ABEO SEC FilingsAbeona Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan
Abeona Therapeutics (NASDAQ:ABEO) Insider Madhav Vasanthavada Sells 12,610 Shares of Stock - MarketBeat
Abeona Therapeutics Inc. (NASDAQ:ABEO) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Abeona Therapeutics CEO Seshadri Vishwas sells $372k in shares By Investing.com - Investing.com India
Abeona Therapeutics CFO Vazzano sells $99k in shares By Investing.com - Investing.com Australia
Abeona Therapeutics (NASDAQ:ABEO) CEO Sells $372,204.56 in Stock - MarketBeat
Joseph Walter Vazzano Sells 18,666 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock - MarketBeat
Abeona Therapeutics CFO Vazzano sells $99k in shares - Investing.com
O’Malley, Abeona Therapeutics SVP, sells $72k in stock By Investing.com - Investing.com South Africa
O’Malley, Abeona Therapeutics SVP, sells $72k in stock - Investing.com
Insider Sell: Mark Alvino Sells 13,500 Shares of Abeona Therapeu - GuruFocus
Abeona Therapeutics (NASDAQ:ABEO) Director Mark Alvino Sells 13,500 Shares - MarketBeat
Breakouts Watch: Is Abeona Therapeutics Inc stock forming a cup and handleDay Trade & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Abeona Therapeutics announces employee inducement grants - MSN
Jobs Data: Is OneWater Marine Inc on track to beat earningsMarket Weekly Review & Long Hold Capital Preservation Plans - baoquankhu1.vn
How (ABEO) Movements Inform Risk Allocation Models - Stock Traders Daily
Published on: 2026-01-17 07:33:28 - baoquankhu1.vn
Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Above 50-Day Moving AverageHere's What Happened - MarketBeat
Cantor Fitzgerald reiterates Overweight rating on Abeona Therapeutics stock By Investing.com - Investing.com Canada
Big Picture: Is Abeona Therapeutics Inc in a bullish channelQuarterly Earnings Report & Weekly Breakout Watchlists - baoquankhu1.vn
Is Abeona Therapeutics Inc. (PCJ) stock inflation resilient2025 Bull vs Bear & Daily Technical Stock Forecast Reports - Улправда
Why Abeona Therapeutics Inc. stock remains a top recommendationJuly 2025 Chart Watch & Proven Capital Preservation Methods - Улправда
How Abeona Therapeutics Inc. stock compares to industry benchmarksWeekly Trend Recap & Weekly High Potential Stock Alerts - Улправда
Will Abeona Therapeutics Inc. (PCJ) stock draw ESG focused funds2026 world cup usa national team round of 32 defensive leaders counter attacking knockout prediction guide - Улправда
Trading Systems Reacting to (ABEO) Volatility - Stock Traders Daily
Abeona Therapeutics Inc Stock (ABEO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):